NCT02091414View on ClinicalTrials.gov

A Study of CellCept (Mycophenolate Mofetil) in Combination Therapy in Heart Transplant Patients.

PHASE3CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

August 31, 2006

Primary Completion Date

February 28, 2009

Study Completion Date

February 28, 2009

Conditions
Heart Transplantation
Interventions
DRUG

mycophenolate mofetil (MMF)

1.0 g PO BID

DRUG

cyclosporine A (CsA)

Initial loading dose of 4 to 6 mg/kg within 48 hours of transplantation, adjusted thereafter to a blood trough concentration of 150 to 300 ng/mL

DRUG

corticosteroids

As per the practice of each participating center

Trial Locations (3)

100029

Beijing

200032

Shanghai

350001

Fuzhou

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT02091414 - A Study of CellCept (Mycophenolate Mofetil) in Combination Therapy in Heart Transplant Patients. | Biotech Hunter | Biotech Hunter